Mechanisms of apoptosis avoidance in cancer
- 1 January 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 11 (1) , 68-75
- https://doi.org/10.1097/00001622-199901000-00014
Abstract
Defects in the programmed cell death mechanisms can extend cell lifespan, contributing to neoplastic cell expansion independently of cell division. Deficiencies in apoptosis also contribute to carcinogenesis by creating a permissive environment for genetic instability and accumulation of gene mutations, permitting disobeyance of cell cycle checkpoints which would normally induce apoptosis, facilitating growth factor- and hormone-independent cell survival, supporting anchorage-independent survival during metastasis, reducing dependence on oxygen and nutrients, promoting resistance to immune-based destruction, and conferring resistance to cytotoxic anticancer drugs and radiation. Though much remains to be learned, identification of gene families that control the physiological cell death pathway has provided the basis for improved understanding of tumor biology. This review describes some of the recent progress made towards delineating the biochemistry and molecular biology of apoptosis control, and briefly summarizes the progress in identifying specific road blocks to apoptosis induction in cancers. These advances are beginning to reveal novel strategies for combating cancer by restoring apoptosis sensitivity.Keywords
This publication has 55 references indexed in Scilit:
- Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of ApoptosisScience, 1998
- Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome cJournal of Biological Chemistry, 1998
- Mtd, a Novel Bcl-2 Family Member Activates Apoptosis in the Absence of Heterodimerization with Bcl-2 and Bcl-XLJournal of Biological Chemistry, 1998
- Movement of Bax from the Cytosol to Mitochondria during ApoptosisThe Journal of cell biology, 1997
- Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2Oncogene, 1997
- Inhibition of Bax Channel-Forming Activity by Bcl-2Science, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.Journal of Clinical Investigation, 1996
- Disruption of epithelial cell-matrix interactions induces apoptosisThe Journal of cell biology, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994